single-payer
A healthcare financing system in which a single public entity pays for care, giving it negotiating leverage over drug prices.
As defined in Marcia Angell on Big Pharma
Where it comes up · 5
- Ed Dolan on Employer-Sponsored Health Insurance2 claims
- Arnold Kling on the Economics of Health Care and the Crisis of Abundance 11/5/20072 claims
- Marcia Angell on Big Pharma1 claim
- Christy Ford Chapin on the Evolution of the American Health Care System1 claim
- Mike Munger on Shortages, Prices, and Competition 10/19/20091 claim
Most important claims · 7 of 7Search all claims for “single-payer” →
- Countries with private providers but government payers (Netherlands, Switzerland, Germany) face the same cost problems and address them with professional associations that evaluate treatments using Quality-Adjusted Life Years (QALYs) and set cutoffs on what is worth paying for—restraints the US lacks, notably in Medicare.Ed Dolan on Employer-Sponsored Health Insurance
- The ideal reform combines a universal/single-payer-style subsidy system (like Switzerland's voucher-style subsidies) that covers the neediest, with substantial rollback of cost-containment regulation (certificate of need, scope-of-practice and licensing limits on nurse practitioners and PAs, restrictions on physician organization) so physicians can organize themselves as in concierge medicine and co-ops, leaving insurers only for catastrophic coverage—correctly incentivizing both physicians and patients.Christy Ford Chapin on the Evolution of the American Health Care System
- The US has unusually high administrative costs for health care because it runs six or seven different fragmented systems—Medicaid, Medicare, VA, ACA, employer-sponsored, and others—so a single payer in the limited sense of administrative simplification (not Medicare-for-All) would yield large benefits.Ed Dolan on Employer-Sponsored Health Insurance
- A single-payer system would not reduce total spending unless government cracks down on procedures, because arithmetically the 'villains' (drug company profits, insurance overhead) are too small to explain the spending surge — which comes from actual specialist and high-tech procedures.Arnold Kling on the Economics of Health Care and the Crisis of Abundance 11/5/2007
- Medicare faces tens of trillions of dollars in unfunded liabilities — the gap between promised future benefits and projected tax revenue — making it the fiscal equivalent of the Titanic; proposals to expand it (single-payer) merely add passengers to a ship headed for that iceberg.Arnold Kling on the Economics of Health Care and the Crisis of Abundance 11/5/2007
- Because drug companies are not the drivers of innovation, a global shift to single-payer systems that use negotiating leverage to cut drug prices would lower industry profits with no negative impact on health outcomes.Marcia Angell on Big Pharma
- A liver transplant costs about $1–1.2 million all-in. Society cannot pay that for everyone, so wealthy people and those with gilt-edged plans get them. Under single-payer systems such as Germany or England, it is reportedly impossible to get one legally in some cases, which is effectively a decision to ration.Mike Munger on Shortages, Prices, and Competition 10/19/2009